Hldgs. Energy Xxl (Bermuda)
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
List of Marginable OTC Stocks
List of Marginable OTC Stocks @ENTERTAINMENT, INC. ABACAN RESOURCE CORPORATION ACE CASH EXPRESS, INC. $.01 par common No par common $.01 par common 1ST BANCORP (Indiana) ABACUS DIRECT CORPORATION ACE*COMM CORPORATION $1.00 par common $.001 par common $.01 par common 1ST BERGEN BANCORP ABAXIS, INC. ACETO CORPORATION No par common No par common $.01 par common 1ST SOURCE CORPORATION ABC BANCORP (Georgia) ACMAT CORPORATION $1.00 par common $1.00 par common Class A, no par common Fixed rate cumulative trust preferred securities of 1st Source Capital ABC DISPENSING TECHNOLOGIES, INC. ACORN PRODUCTS, INC. Floating rate cumulative trust preferred $.01 par common $.001 par common securities of 1st Source ABC RAIL PRODUCTS CORPORATION ACRES GAMING INCORPORATED 3-D GEOPHYSICAL, INC. $.01 par common $.01 par common $.01 par common ABER RESOURCES LTD. ACRODYNE COMMUNICATIONS, INC. 3-D SYSTEMS CORPORATION No par common $.01 par common $.001 par common ABIGAIL ADAMS NATIONAL BANCORP, INC. †ACSYS, INC. 3COM CORPORATION $.01 par common No par common No par common ABINGTON BANCORP, INC. (Massachusetts) ACT MANUFACTURING, INC. 3D LABS INC. LIMITED $.10 par common $.01 par common $.01 par common ABIOMED, INC. ACT NETWORKS, INC. 3DFX INTERACTIVE, INC. $.01 par common $.01 par common No par common ABLE TELCOM HOLDING CORPORATION ACT TELECONFERENCING, INC. 3DO COMPANY, THE $.001 par common No par common $.01 par common ABR INFORMATION SERVICES INC. ACTEL CORPORATION 3DX TECHNOLOGIES, INC. $.01 par common $.001 par common $.01 par common ABRAMS INDUSTRIES, INC. ACTION PERFORMANCE COMPANIES, INC. 4 KIDS ENTERTAINMENT, INC. $1.00 par common $.01 par common $.01 par common 4FRONT TECHNOLOGIES, INC. -
By in Vivo's Biopharma, Medtech and Diagnostics Teams
invivo.pharmaintelligence.informa.com JANUARY 2018 Invol. 36 ❚ no. 01 Vivopharma intelligence ❚ informa 2018 OUTLOOK By In Vivo’s Biopharma, Medtech and Diagnostics Teams PAGE LEFT BLANK INTENTIONALLY invivo.pharmaintelligence.informa.com STRATEGIC INSIGHTS FOR LIFE SCIENCES DECISION-MAKERS CONTENTS ❚ In Vivo Pharma intelligence | January 2018 BIOPHARMA MEDTECH 2018 DIAGNOSTICS OUTLOOK 12 22 28 Biopharma 2018: Medtech 2018: Diagnostics 2018: Is There Still A Place For Pharma The Place For Innovation Steady Progress And In The New Health Care As Value-based Health Care The Big Get Bigger Economy? Gains Momentum MARK RATNER WILLIAM LOONEY ASHLEY YEO If the beginning of 2017 was marked 2018 will be a time of transition in health 2017 was a watershed year in many by doubts around whether and how care, when biopharma’s counterparts respects, politically, economically the FDA would act with respect to in adjacent industry segments scale up and commercially for many players complex diagnostics, we enter 2018 in a radical redesign of their traditional in the medtech field. Where will the feeling that slow-moving vessel may business models. Biopharma is not opportunities lie in 2018? Will finally be turning. moving as quickly, and it confronts a breakthrough medtech innovation still strategic dilemma on how to address the have a place among providers often prospect of a much more powerful set of riding on fumes when it comes to 36 rivals in the ongoing battle to own the budgets, and is it all as bad as some patient experience in medicine. would make out? Thirty-five Years Covering Health Care: The More Things Change… 30 PETER CHARLISH A Virtuous Cycle: What The The health care industry has come a Immuno-Oncology Revolution long way in the past 35 years, although Means For Other Disease Areas in some areas very little has changed. -
Former Westernbank Chiefs Seek to Toss $176M FDIC Suit - Law360
Former Westernbank Chiefs Seek To Toss $176M FDIC Suit - Law360 http://www.law360.com/banking/articles/329418/former-westernbank-chi... Advanced Search (/advanced_search) News, cases, companies, firms Search (#) (/subscribe) News Sections (#AllSections) Alerting Tools (#Tools) Jobs (/jobs/seeker) [email protected] Former Westernbank Chiefs Seek To Toss $176M FDIC Suit Got an idea for a story? Email [email protected] By Jamie Santo Share us on: (mailto:[email protected]). (/articles/329418 Got the inside scoop but Law360, New York (April 12, 2012, 8:06 PM ET) -- prefer to stay out of the spotlight? /print?section=banking) Executives and directors of the now-defunct Westernbank (/articles/329418 Email [email protected] Puerto Rico asked a federal judge Wednesday to dismiss (mailto:[email protected]). /share?section=banking) a $176 million Federal Deposit Insurance Corp (/agencies (/about /rights_and_reprints?article_id=329418) /federal-deposit-insurance-corp). suit accusing the group Banking of gross negligence in its handling of loans prior to the (/about/editorial_contacts) CFPB Tells 3rd Circ. Home Loan Rescission Documents bank's closure in 2010. Suits Valid (/banking/articles/330539/cfpb- tells-3rd-circ-home-loan-rescission-suits- Dismiss valid) (http://articles.law360.s3.amazonaws.com In a motion filed in the U.S.district court in Puerto Rico, the Case Information The Consumer Financial Protection Bureau on Friday six former Westernbank executives and directors argue urged the Third Circuit to allow more flexibility for loan Case Title recipients who have allegedly legally rescinded home loans to pursue legal action against lenders who fail to that the FDIC (/agencies/federal-deposit-insurance- W Holding Company, Inc. -
Infectious Diseases
2013 MEDICINES IN DEVELOPMENT REPORT Infectious Diseases A Report on Diseases Caused by Bacteria, Viruses, Fungi and Parasites PRESENTED BY AMERICA’S BIOPHARMACEUTICAL RESEARCH COMPANIES Biopharmaceutical Research Evolves Against Infectious Diseases with Nearly 400 Medicines and Vaccines in Testing Throughout history, infectious diseases hepatitis C that inhibits the enzyme have taken a devastating toll on the lives essential for viral replication. and well-being of people around the • An anti-malarial drug that has shown Medicines in Development world. Caused when pathogens such activity against Plasmodium falci- For Infectious Diseases as bacteria or viruses enter a body and parum malaria which is resistant to multiply, infectious diseases were the current treatments. Application leading cause of death in the United Submitted States until the 1920s. Today, vaccines • A potential new antibiotic to treat methicillin-resistant Staphylococcus Phase III and infectious disease treatments have proven to be effective treatments in aureus (MRSA). Phase II many cases, but infectious diseases still • A novel treatment that works by Phase I pose a very serious threat to patients. blocking the ability of the smallpox Recently, some infectious pathogens, virus to spread to other cells, thus 226 such as pseudomonas bacteria, have preventing it from causing disease. become resistant to available treatments. Infectious diseases may never be fully Diseases once considered conquered, eradicated. However, new knowledge, such as tuberculosis, have reemerged new technologies, and the continuing as a growing health threat. commitment of America’s biopharma- America’s biopharmaceutical research ceutical research companies can help companies are developing 394 medicines meet the continuing—and ever-changing and vaccines to combat the many threats —threat from infectious diseases. -
U.S. SBA Office of Advocacy--Small and Micro Business Lending For
Office of Advocacy www.sba.gov/advo Advocacy: the voice of small business in government Small Business and Micro Business Lending in the United States for Data Years 2008-2009 Office of Advocacy U.S. Small Business Administration December 2010 Created by Congress in 1976, the Office of Advocacy of the U.S. Small Business Administration (SBA) is an independent voice for small business within the federal government. Appointed by the President and confirmed by the U.S. Senate, the Chief Counsel for Advocacy directs the office. The Chief Counsel advances the views, concerns, and interests of small business before Congress, the White House, federal agencies, federal courts, and state policy makers. Economic research, policy analyses, and small business outreach help identify issues of concern. Regional Advocates and an office in Washington, D.C., support the Chief Counsel’s efforts. For more information on the Office of Advocacy, visit www.sba.gov/advo or call (202) 205-6533. Receive email notices of new Office of Advocacy information by signing up on Advocacy’s Listservs at http://web.sba.gov/list. þ ADVOCACY NEWSLETTER þ ADVOCACY PRESS þ ADVOCACY REGULATORY NEWS þ ADVOCACY RESEARCH Foreword This edition of the Office of Advocacy’s annual study of lending to small and micro businesses by most depository institutions in the United States continues the expanded coverage of previous editions. In addition to banks, other depository institutions such as federal and state savings banks and savings and loan associations are included. Geographic coverage includes the United States and its territories. The two types of data used in this study are based on reports made by depository institutions to their respective regulating agencies—Call Reports for June 2009 and Community Reinvestment Act (CRA) reports for 2008. -
Oklahoma City Channel Lineup
Name Call Letters Number Name Call Letters Number Name Call Letters Number Fox College Sports - Central ** FCSC 648 Nicktoons NKTN 316 ActionMAX ACTMAX 835 Oklahoma City Fox College Sports - Pacific ** FCSP 649 Noggin NOG 320 Cinemax MAX 832 Fox Movie Channel FMC 792 Oxygen OXGN 368 Cinemax - West MAX-W 833 Fox News Channel FNC 210 PBS KIDS Sprout SPROUT 337 Encore ENC 932 Fox Reality Channel REAL 130 qubo qubo 328 Encore - West ENC-W 933 Channel Directory Fox Soccer Channel ** FSC 654 QVC QVC 197 Encore Action ENCACT 936 BY CHANNEL NAME Fox Sports en Español ** FSE 655 QVC QVC 420 Encore Drama ENCDRA 938 FSN Arizona ** FSAZ 762 Recorded TV Channel DVR 9999 Encore Love ENCLOV 934 FSN Detroit ** FSD 737 Sci Fi Channel SCIFI 151 Encore Mystery ENCMYS 935 Name Call Letters Number FSN Florida ** FSFL 720 Science Channel SCI 258 Encore Wam WAM 939 FSN Midwest ** FSMW 748 ShopNBC SHPNBC 424 Encore Westerns ENCWES 937 FSN North ** FSN 744 SiTV SiTV 194 FLIX FLIX 890 LOCAL LISTINGS FSN Northwest ** FSNW 764 Sleuth SLEUTH 161 HBO HBO 802 FSN Ohio-Cincinnati ** FSOHCI 732 Smile of a Child SMILE 340 HBO - West HBO-W 803 HSN HSN 8 FSN Ohio-Cleveland ** FSOHCL 734 SOAPnet SOAP 365 HBO Comedy HBOCOM 808 KAUT-43 (MY NETWORK TV) KAUT 43 FSN Pittsburgh ** FSP 730 SOAPnet - West SOAP-W 366 HBO Family HBOFAM 806 KETA-13 (PBS) KETA 13 FSN Prime Ticket ** FSPT 774 Speed Channel ** SPEED 652 HBO Latino HBOLAT 810 KFOR-4 (NBC) KFOR 4 FSN Rocky Mountain ** FSRM 760 Spike TV SPKE 145 HBO Signature HBOSIG 807 KOCB-34 (THE CW) KOCB 34 FSN South ** FSS 724 Spike -
FIC-Prop-65-Notice-Reporter.Pdf
FIC Proposition 65 Food Notice Reporter (Current as of 9/25/2021) A B C D E F G H Date Attorney Alleged Notice General Manufacturer Product of Amended/ Additional Chemical(s) 60 day Notice Link was Case /Company Concern Withdrawn Notice Detected 1 Filed Number Sprouts VeggIe RotInI; Sprouts FruIt & GraIn https://oag.ca.gov/system/fIl Sprouts Farmers Cereal Bars; Sprouts 9/24/21 2021-02369 Lead es/prop65/notIces/2021- Market, Inc. SpInach FettucIne; 02369.pdf Sprouts StraIght Cut 2 Sweet Potato FrIes Sprouts Pasta & VeggIe https://oag.ca.gov/system/fIl Sprouts Farmers 9/24/21 2021-02370 Sauce; Sprouts VeggIe Lead es/prop65/notIces/2021- Market, Inc. 3 Power Bowl 02370.pdf Dawn Anderson, LLC; https://oag.ca.gov/system/fIl 9/24/21 2021-02371 Sprouts Farmers OhI Wholesome Bars Lead es/prop65/notIces/2021- 4 Market, Inc. 02371.pdf Brad's Raw ChIps, LLC; https://oag.ca.gov/system/fIl 9/24/21 2021-02372 Sprouts Farmers Brad's Raw ChIps Lead es/prop65/notIces/2021- 5 Market, Inc. 02372.pdf Plant Snacks, LLC; Plant Snacks Vegan https://oag.ca.gov/system/fIl 9/24/21 2021-02373 Sprouts Farmers Cheddar Cassava Root Lead es/prop65/notIces/2021- 6 Market, Inc. ChIps 02373.pdf Nature's Earthly https://oag.ca.gov/system/fIl ChoIce; Global JuIces Nature's Earthly ChoIce 9/24/21 2021-02374 Lead es/prop65/notIces/2021- and FruIts, LLC; Great Day Beet Powder 02374.pdf 7 Walmart, Inc. Freeland Foods, LLC; Go Raw OrganIc https://oag.ca.gov/system/fIl 9/24/21 2021-02375 Ralphs Grocery Sprouted Sea Salt Lead es/prop65/notIces/2021- 8 Company Sunflower Seeds 02375.pdf The CarrIngton Tea https://oag.ca.gov/system/fIl CarrIngton Farms Beet 9/24/21 2021-02376 Company, LLC; Lead es/prop65/notIces/2021- Root Powder 9 Walmart, Inc. -
Federal Register/Vol. 85, No. 103/Thursday, May 28, 2020
32256 Federal Register / Vol. 85, No. 103 / Thursday, May 28, 2020 / Proposed Rules FEDERAL COMMUNICATIONS closes-headquarters-open-window-and- presentation of data or arguments COMMISSION changes-hand-delivery-policy. already reflected in the presenter’s 7. During the time the Commission’s written comments, memoranda, or other 47 CFR Part 1 building is closed to the general public filings in the proceeding, the presenter [MD Docket Nos. 19–105; MD Docket Nos. and until further notice, if more than may provide citations to such data or 20–105; FCC 20–64; FRS 16780] one docket or rulemaking number arguments in his or her prior comments, appears in the caption of a proceeding, memoranda, or other filings (specifying Assessment and Collection of paper filers need not submit two the relevant page and/or paragraph Regulatory Fees for Fiscal Year 2020. additional copies for each additional numbers where such data or arguments docket or rulemaking number; an can be found) in lieu of summarizing AGENCY: Federal Communications original and one copy are sufficient. them in the memorandum. Documents Commission. For detailed instructions for shown or given to Commission staff ACTION: Notice of proposed rulemaking. submitting comments and additional during ex parte meetings are deemed to be written ex parte presentations and SUMMARY: In this document, the Federal information on the rulemaking process, must be filed consistent with section Communications Commission see the SUPPLEMENTARY INFORMATION 1.1206(b) of the Commission’s rules. In (Commission) seeks comment on several section of this document. proceedings governed by section 1.49(f) proposals that will impact FY 2020 FOR FURTHER INFORMATION CONTACT: of the Commission’s rules or for which regulatory fees. -
Audubon Society of Portland
Audubon Society of Portland 2015–2016 Annual Report Welcome to our 2016 Annual Report, the first I’ve had Financially, we outperformed our budget, and invested the honor to introduce as Executive Director. Precious few resources to improve our efficiency and effectiveness. We’ve organizations have Portland Audubon’s ability both to maintained a coveted 4-star rating from Charity Navigator connect people from all walks of life with nature, and to by committing over 80 percent of every dollar raised to inspire them to act for its protection. We’ve been at this directly support our mission. That efficiency level is possible since 1902 when we helped establish three of the first because we are truly a volunteer-empowered organization: wildlife refuges on the West Coast—places like Malheur— with 450 extraordinary volunteers providing 40 percent of and we’ve been going full speed ever since. Conservation our workforce. requires constant vigilance, and a bold vision for the future. Each and every day, our community of Audubon members 2016 was another strong year. On the ground, we were and supporters works to expand our bond with nature that instrumental in several of the greatest conservation issues its future depends upon. We hope that you find this report to impact our state, as well as the nation. At Malheur on our progress inspiring at an important and uncertain National Wildlife Refuge, we galvanized supporters to stand time for protecting our planet. Thank you for your role in up for public lands, and helped focus media on the real making it happen. -
List of Section 13F Securities
List of Section 13F Securities 1st Quarter FY 2004 Copyright (c) 2004 American Bankers Association. CUSIP Numbers and descriptions are used with permission by Standard & Poors CUSIP Service Bureau, a division of The McGraw-Hill Companies, Inc. All rights reserved. No redistribution without permission from Standard & Poors CUSIP Service Bureau. Standard & Poors CUSIP Service Bureau does not guarantee the accuracy or completeness of the CUSIP Numbers and standard descriptions included herein and neither the American Bankers Association nor Standard & Poor's CUSIP Service Bureau shall be responsible for any errors, omissions or damages arising out of the use of such information. U.S. Securities and Exchange Commission OFFICIAL LIST OF SECTION 13(f) SECURITIES USER INFORMATION SHEET General This list of “Section 13(f) securities” as defined by Rule 13f-1(c) [17 CFR 240.13f-1(c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [17 CFR 240.13f-1] under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of March 15, 2004, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending March 31, 2004. Institutional investment managers should report holdings--number of shares and fair market value--as of the last day of the calendar quarter as required by Section 13(f)(1) and Rule 13f-1 thereunder. -
Dollar Tree, Inc
Feltl and Company Research Department 225 South Sixth Street, Suite 4200 Minneapolis, MN 55402 1.866.655.3431 Brent R. Rystrom [email protected] | 612.492.8810 Dollar Tree, Inc. Consumer- Retail Au gust 12, 2009 Company Description: Dollar Tree is the leading participant in the Extreme Value Retailing sector, one of the strongest sectors in the US retailing. DLTR operates over 3700 stores in 48 states, and is growing its units by 6% annually while delivering double-digit earnings growth. DLTR is based in Chesapeake, Virginia. Initiating Coverage (DLTR - $46.03) Strong Buy Key Points Financial Summary We are initiating research coverage of Dollar Tree with a Strong Buy rating and a $62 price target. Dollar Tree (DLTR) is the leading participant in the Extreme Value Retailing category. DLTR delivers strong unit growth, generally healthy same-store sales Rev(mil) 2008A 2009E 2010E results, compelling margins, and exceptional EPS growth and return on investment. Apr $1,051 $1,201A $1,281E In almost every one of these metrics, it outperforms almost all peers, both direct in Jul $1,093 $1,220A $1,320E the EVR category and in other major retailing sectors. Oct $1,114 $1,206E $1,311E Jan $1,387 $1,522E $1,662E DLTR operates one of the most profitable store concepts in retail. Its Dollar FY $4,645 $5,140E $5,573E Tree stores generate sales in excess of $1.3 million, contribution margins near P/Sales 0.90x 0.81x .83x $140,000, and earn about 100% annually on store-level investment. This generates substantial cash flows that easily fund operations while providing excess cash flows for other purposes. -
Jan Bormeth Vilhelmsen Og Ma
0 ucvbnmqwertyuiopåasdfghjklæøzxcv Executive Summary The master thesis at hand is a study of the Danish retail store chain Tiger and EQT’s decision to acquire a 70% stake in the company. The aim in this thesis is twofold. Firstly, a valuation of Zebra per June 30, 2015, will be conducted. Secondly, an analysis of the value creation during EQT’s ownership period is performed. The main objective in this thesis is to estimate the fair Enterprise Value per June 30, 2015, through a DCF-analysis. Based on Zebra’s strategic position and its historical financial performance, the expected future earnings and cash flow generations were forecasted and resulted in an Enterprise Value of DKK 8,864 million from which the Group accounted for DKK 8,350 million and the Japanese Joint Venture for DKK 515 million. Based on these figures, Zebra’s fair value of equity comprises DKK 7,789 million. Of this figure, EQT’s share of the equity amounts to DKK 5,219 million and DKK 2,874 million when correcting for the 50/50 owned subsidiaries. At EQT’s entry in the beginning of 2013, the purchase price for its stake was DKK 1,600 million, according to different sources, resulting in an IRR for EQT on 26.48% per year. This IRR is satisfying since it is above the expected return for Private Equity investments which historically has a threshold for an IRR on over 20% per year, and in more recent time a threshold between 12-17% per year. The objective in the second part of this thesis is to analyze how EQT has created or destroyed value during its ownership period based on an IRR for Zebra, excluding the Japanese Joint Venture.